|If you are having trouble viewing this email please click here
- June 2011
- The E-newsletter of the American Academy of Pain Management
Click here to register for the 22nd Annual Clinical Meeting
Caesars Palace Las Vegas, NV. September 20-23, 2011
This E-newsletter is made possible, in part, by educational grants from the following sponsors:
The American Academy of Pain Management is an inclusive, interdisciplinary/ integrative organization serving clinicians who treat people with pain through education, setting standards of care, and advocacy.
Become a Member!
Pain Studies In The News
Behavioral treatment for migraines a cost-effective alternative to meds
July 6, 2011 Source: University of Mississippi Medical Center
Treating chronic migraines with behavioral approaches - such as relaxation training, hypnosis and biofeedback - can make financial sense compared to prescription-drug treatment, especially after a year or more, a new study found. The researchers found that after six months, the cost of minimal-contact behavioral treatment was competitive with pharmacologic treatments using drugs costing 50 cents or less a day.
Botulinum toxin does not cure common forms of neck pain
July 6, 2011 Source: Wiley-Blackwell
There is no evidence that botulinum toxin injections reduce chronic neck pain or associated headaches, says a group of scientists who reviewed nine trials involving a total of 503 participants. The researchers also believe that trials should be run that look at other symptoms than pain, such as function, to see if there is any reason for believing that BoNT can provide some benefit.
Massage eases low back pain in randomized controlled trial
July 5, 2011 Source: Group Health Research Institute
Massage therapy helps ease chronic low back pain and improve function, according to a new trial. The first study, which is the first to compare structural and relaxation (Swedish) massage, found that both types of massage worked well, with few side effects. At 10 weeks, more than one in three patients who received either type of massage -- but only one in 25 patients who got usual care -- said their back pain was much better or gone.
10 More Pain Studies In The News
Dentists' role in painkiller abuse examined
July 3, 2011 Source: Brown University
Dentists write the third-most prescriptions for immediate release opioids in the United States, but they often don't know the appropriate number of doses to prescribe, how many doses a patient uses, or most importantly what patients do with the leftover tablets they have. A group of nine dentists, pharmacists, and addiction experts provides new research and recommendations to help dentists combat, rather than contribute to, abuse of addictive painkillers.
IOM report calls for cultural transformation of attitudes toward pain and its prevention and management
June 30, 2011 Source: National Academy of Sciences
Every year, at least 116 million adult Americans experience chronic pain, a condition that costs the nation between $560 billion and $635 billion annually, says a new report. Much of this pain is preventable or could be better managed, added the committee that wrote the report. It calls for coordinated, national efforts of public and private organizations to create a cultural transformation in how the nation understands and approaches pain management and prevention.
6 More Pain Studies In The News
For Your Patients
New resource for Hispanic Americans with pain
June 2011 Source: American Pain Foundation
American Pain Foundation (APF) launches "Explain Your Pain" initiative to educate and empower Hispanic Americans about chronic pain and foster improved dialogue between people with pain and their health care providers. An "Explain Your Pain" brochure, available in Spanish and English contains a convenient self-assessment worksheet for people with pain to track how their pain feels, where it hurts and when they hurt to help them communicate their pain to their health care provider. Learn more about the initiative.
Product News/Clinical Trial Results
Pfizer, Acura abuse-resistant painkiller gets FDA nod
Pfizer Inc and Acura Pharmaceuticals Inc said U.S. health regulators approved their pain drug, designed to combat the widespread abuse of opioid-based painkillers. The tablet, Oxecta, was approved by the U.S. Food and Drug Administration for the treatment of acute and chronic moderate to severe pain in cases where use of an opioid painkiller is suitable.
FDA approves Lazanda® - first fentanyl nasal spray - for the management of breakthrough pain in cancer patients
July 1, 2011 Source: Archimedes Pharma Ltd.
The U.S. Food and Drug Administration has approved Lazanda® (fentanyl) nasal spray for the management of breakthrough pain in cancer patients 18 years of age and older who are already receiving and who are tolerant to opioid therapy for their underlying persistent cancer pain. Lazanda is marketed as PecFent® (fentanyl pectin nasal spray) in Europe, where it is presently available in five countries.
10 More Product News and Clinical Trial Results
Power of language — Communicate, empower and create change!
July 2011 Source: American Pain Foundation
Even though more than one in four Americans age 20 years and older report they have had a problem with pain, it is woefully misunderstood. People with pain are often viewed as physically and emotionally weak or labeled as attention seekers or addicts. July's Action of the Month is to use the power of language to combat these stereotypes and misconceptions! Review APF's Power of Language tip sheet and use it to guide the way you speak about your pain, the pain of your patients, or that of your loved one.
Subscribe to The Pain Practitioner!
See sample article below:
The Brain In Pain, by Christine Rhodes, MS (article)
If you are a member of the Academy, you are entitled to many excellent benefits including The Pain Practitioner
, our quarterly magazine. If you are not an Academy member,
you can subscribe for just $35 a year!
Stay up-to-date on the latest research! This section offers complete abstracts on a wide variety of pain and pain management topics that have been selected from the National Library of Medicine.
Apeldoorn AT, Bosselaar H, Ostelo RW, et al.
Identification of patients with chronic low back pain who might benefit from additional psychological assessment.
The Clinical journal of pain. 2011 Jun 14. [forthcoming]
Brennan SA, Harney T, Queally JM, et al.
Influence of weather variables on pain severity in end-stage osteoarthritis.
International orthopaedics. 2011 Jun 29. [forthcoming]
Cao H, Hu H, Colagiuri B, et al.
Medicinal cupping therapy in 30 patients with fibromyalgia: a case series
Forschende Komplementärmedizin (2006). 2011;18(3):122-6.
Munk N, Kruger T, Zanjani F.
Massage therapy usage and reported health in older adults experiencing persistent
Journal of alternative and complementary medicine (New York, N.Y.). 2011 Jun 13. [forthcoming]
Passik SD, Lowery A.
Psychological variables potentially implicated in opioid-related mortality as observed in clinical practice.
Pain medicine (Malden, Mass.). 2011 Jun;12 Suppl 2:S36-42.
Wolter T, Kiemen A, Kaube H.
High cervical spinal cord stimulation for chronic cluster headache.
Cephalalgia. 2011 Jun 23. [forthcoming]
272 More Research Abstracts
State/Branch: California. Assembly
Title: AB 507
Summary: Repeals a provision of existing law that authorizes the Department of Justice to employ a physician to interview and examine any patient in connection with prescription, possession, or use of a controlled substance and requires the patient to submit to the interview and examination, and authorizes the physician to testify in administrative proceedings. Conforms findings and declarations and other references to severe chronic intractable pain and to the State Intractable Pain Treatment Act.
Latest Action: 07/01/2011 In Senate. Read second time and amended. Re-referred to Committee on Appropriations.
03/03/2011 To Assembly Committees on Health and Business, Professions and Consumer Protection.
03/21/2011 From Assembly Committee on Health with author's amendments.
03/21/2011 In Assembly. Read second time and amended. Re-referred to Committee on Health.
04/13/2011 From Assembly Committee on Health with author's amendments.
04/13/2011 In Assembly. Read second time and amended. Re-referred to Committee on Health.
04/26/2011 From Assembly Committee on Health: Do pass to Committee on Business, Professions and Consumer Protection.
04/27/2011 From Assembly Committee on Business, Professions and Consumer Protection with author's amendments.
04/27/2011 In Assembly. Read second time and amended. Re-referred to Committee on Business, Professions and Consumer Protection.
05/03/2011 From Assembly Committee on Business, Professions and Consumer Protection: Do pass to Committee on Appropriations.
05/11/2011 From Assembly Committee on Appropriations: Do pass.
05/16/2011 In Assembly. Read second time. To third reading.
05/19/2011 In Assembly. Read third time. Passed Assembly. *To Senate.
06/02/2011 To Senate Committee on Business, Professions and Economic Development.
06/20/2011 From Senate Committee on Business, Professions and Economic Development with author's amendments.
06/20/2011 In Senate. Read second time and amended. Re-referred to Committee on Business, Professions and Economic Development.
06/27/2011 From Senate Committee on Business, Professions and Economic Development: Do pass as amended to Committee on Appropriations.
07/01/2011 In Senate. Read second time and amended. Re-referred to Committee on Appropriations.
37 More Legislative Updates
Practice guidelines for the management of low back pain [Mexico]
Neerkin J, Cheung CC, Stirling C
Guidelines for Cancer Pain Management in Substance Misusers
Institute for Clinical Systems Improvement
Diagnosis and treatment of headache
Plymouth NHS (UK)
Community Management and Sentinel Referral Guidelines for Patients with Chronic Neck Pain
Nervous System Diseases
Attal N, Cruccu G, Baron R, et al
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
Nervous System Diseases
Cruccu G, Sommer C, Anand P, et al.
EFNS guidelines on neuropathic pain assessment: revised 2009
Nervous System Diseases
Haanpää M, Attal N, Backonja, et al
NeuPSIG guidelines on neuropathic pain assessment
University of Michigan Health System
Managing chronic non-terminal pain in adults including prescribing controlled substances
Guidelines and Audit Implementation Network
General palliative care guidelines for the management of pain at the end of life in adult patients
Summary: A study to determine if the intra-articular injection of a new viscoelastic hydrogel is superior to placebo in subjects with symptomatic osteoarthritis of the knee.
47 More New Clinical Trials
Title: Handbook of Pediatric Chronic Pain
Editor: McClain, Brenda C. & Suresh, Santhanam
Publisher/ Date: Springer, 2011
Summary: In contrast to the days when children were thought to experience less pain than adults, we now know that this is not the case and that prolonged exposure to pain may predispose children to chronic pain syndromes later in life. For these reasons, pain management has become an essential part of pediatric care. Pediatric Chronic Painreflects current advances in the field, offering the pediatric specialist a comprehensive evidence base for the understanding, accurate assessment, and developmentally appropriate treatment of pain in children, from neonates to adolescents. The work of respected physicians and psychologists, this practical guide provides definitive information on frequently encountered syndromes, assessment tools, a wide range of mainstream and complementary intervention strategies (with special attention to opioid tolerance and tapers), and palliative care. Its groundbreaking coverage:
1 More Book
Discovery of why sunburn hurts could lead to new pain relief for inflammatory conditions
July 7, 2011 Source: King's College London
Researchers have found a molecule in the body which controls sensitivity to pain from UVB irradiation, identifying it as a new target for medicines to treat pain caused by other common inflammatory conditions. The molecule, called CXCL5, is part of a family of proteins called chemokines, which recruit inflammatory immune cells to the injured tissue, triggering pain and tenderness. This is the first study to reveal this molecule's role in mediating pain.
1 More Lagniappe
The American Academy of Pain Management is the nation's largest interdisciplinary/integrative organization
who treat people with pain through education, setting standards of care, and advocacy.
Academy Website|Become a Member!|Classified Ads|Corporate Members|Contact Us|About Us
If you no longer wish to recieve this newsletter please unsubscribe here.
|© 2011 American Academy of Pain Management